BioMed Research International
Volume 2014 (2014), Article ID 472562, 9 pages
http://dx.doi.org/10.1155/2014/472562

Clinical Study

Speckle-Tracking and Tissue-Doppler Stress Echocardiography in Arterial Hypertension: A Sensitive Tool for Detection of Subclinical LV Impairment

Kai O. Hensel,1,2 Andreas Jenke,² and Roman Leischik¹

¹Department of Cardiology, Faculty of Health, School of Medicine, Witten/Herdecke University, Elberfelderstraße 1, 58095 Hagen, Germany
²HELIOS Children’s Hospital Wuppertal, Faculty of Health, Witten/Herdecke University, 42283 Wuppertal, Germany

Received 29 April 2014; Accepted 6 August 2014; Published 15 October 2014

Academic Editor: Michael Gotzmann

Copyright © 2014 Kai O. Hensel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Early diagnosis of cardiac alterations in hypertensive heart disease is still challenging. Since such patients might have depressed global LV systolic strain or strain rate when EF is still normal, speckle-tracking echocardiography (STE) and tissue-Doppler imaging (TDI) combined with stress echocardiography might improve early diagnosis of cardiac alterations. In this prospective study standard 2D Doppler echocardiography, STE, and TDI were performed at rest and during bicycle exercise in 92 consecutive patients—46 hypertensive subjects with normal ejection fraction and 46 healthy controls. STE and TDI were used to measure global peak systolic LV circumferential strain (CS), longitudinal strain (LS), and longitudinal strain rate (SR). Mean arterial blood pressure was significantly higher in hypertensive patients at rest (100.8 mmHg SD 13.5 mmHg; ) and during physical exercise testing (124.2 mmHg SD 13.4 mmHg; ). Hypertensive patients had significantly reduced values of systolic CS (), LS (), and SR () at rest as well as during physical exercise—CS (), LS (), and SR (). Using STE and TDI, reduced LV systolic strain and strain rate consistent with early cardiac alterations can be detected in patients with arterial hypertension. These findings were evident at rest and markedly pronounced during exercise echocardiography.

1. Introduction

Cardiovascular diseases are the most common causes of death in the western world accounting for more than one million of deaths annually in USA [1]. One major risk factor for cardiovascular morbidity and mortality worldwide is arterial hypertension (HTN) [2]. Longstanding HTN leads to left ventricular hypertrophy which has been proven to directly predispose to and aggravate irreversible deterioration of LV function and ultimately results in congestive heart failure [3, 4]. In patients with arterial hypertension, it is therefore crucial to detect LV impairment as early as possible in order to identify patients at high risk for heart failure. Given the high incidence of HTN this is not only important for prognosis, optimal prevention, and treatment strategies in order to improve the overall outcome, but also crucial to reduce the burden of the disease from an economical point of view.

Currently, the gold standard in echocardiographically quantifying systolic left ventricular (LV) function is the ejection fraction (EF) [5]. However, measurement of EF is a simplistic approach, closely correlated to the radial component of myocardial deformation and does not account for the complex three-dimensional deformation with the important longitudinal and circumferential plane. As a consequence, the assessment of EF only detects deterioration in LV function in a relatively advanced state [6]. Subtle changes in myocardial deformation occur prior to the more extensive impairment of the LV that is detectable by changes in EF. In fact, experimental studies of isolated papillary muscles in the setting of chronic pressure overload showed depressed contractility despite normal EF [7–9]. Thus early stages of impaired LV function—when therapeutic intervention might be most beneficial—remain undetected [10].

Strain—defined as myocardial deformation expressed in percent—has been proven to discriminate between hypertensive heart disease, hypertrophic cardiomyopathy, and athletes’ hearts [11, 12]. This differentiation is possible because regional deformation may be reduced in hypertrophic cardiomyopathy whereas it may be unchanged or hypercontractile in athletes’ hearts. Novel quantitative techniques in echocardiographic deformation imaging such as speckle-tracking imaging (STE) [13] and tissue-Doppler imaging (TDI) [14] can reliably measure LV strain and therefore bare incremental diagnostic potentialities for populations with hypertensive heart disease [15]. STE and TDI make use of different physical techniques in order to measure strain: STE utilizes a two-dimensional greyscale B-mode image [16]. TDI makes use of the well-known Doppler phenomenon. Both STE and TDI have been shown to be more sensitive for detection of subtle changes in LV deformation than EF [17, 18]. TDI was also proven to be useful in order to differentiate between pathologic and physiologic LV hypertrophy [19, 20].

In this study, we tested quantitative deformation stress echocardiography as a diagnostic tool for early detection of cardiac malfunction due to arterial hypertension. We aimed to analyze whether measurement of myocardial strain and strain rate with STE and TDI can detect subclinical LV systolic deformation abnormalities in patients with mild arterial hypertension and preserved EF at rest and during physical stress echocardiography. Subsequently, a direct comparison of the two methods during exercise echocardiography was performed. Depressed strain (rate) values in patients with arterial hypertension might serve clinicians as potential indicators to target preventive diagnostics and potentially the extent of treatment.

2. Methods

2.1. Patient Characteristics

In this prospective study we examined a total of 92 consecutive subjects (47 women, 45 men; ) at practice for Cardiology and Sport Medicine in Hagen/Germany. The study group consists of 46 patients (male/female ratio 1.09; mean age 46.6 years; standard deviation (SD) 14.4) with mild arterial hypertension with sufficient treatment for blood pressure (BP) control according to the ACCF/AHA guidelines [21] (Table 1). The control group included 46 healthy controls (male/female ratio 0.84; mean age 44 SD 22.5). Inclusion criteria for patients in the study group were the diagnosis of isolated, essential arterial hypertension for at least 5 years before being included in this study. None of the included patients suffered from end-organ damage such as evidence of renal failure or retinal changes. Diagnosis was made according to the 7th report of the Joint National Committee [21]. Other cardiovascular or noncardiovascular comorbidities that may have an influence on the cardiovascular system such as diabetes mellitus, atrial fibrillation, history of angina pectoris, and coronary artery disease were strict exclusion criteria. Further, a thorough history and physical examination and both resting and exercise echocardiography and EKG were obtained.

Table 1: Antihypertensive therapy regimen in the study group; control subjects were under no influence of antihypertensive medication.

Hypertensive Patients ()

Behavioural/nutritional management only
14

Beta-Blocker
9

ACE-/AT1-Inhibitor
7

Beta-Blocker and ACE-/AT1-Inhibitor
9

Beta-Blocker, ACE-/AT1-Inhibitor and Ca-Antagonist
7

Participants in the control group had completely negative medical history with regard to the cardiovascular as well as to any other organ system. Each participant was informed about purpose and procedure of the study and provided a written consent. The study protocol was approved by the Witten/Herdecke University ethics committee.

2.2. Standard Echocardiographic Examination

The echocardiographic examination was performed with the commercially available ultrasound device VIVID 7 Dimension by General Electrics (GE) Medical Systems GmbH, Germany. The ultrasound probe used was a “Matrix Array,” Sector 1.5–4.3 MHz. The recorded data was stored and later analyzed with the offline-workstation software EchoPAC Dimension [5.2.0, General Electrics (GE) Medical Systems GmbH, Germany] by two experienced, independent, cardiologists, blinded to both groups.

Transthoracic echocardiography was performed in the left lateral decubitus position. The following measurements with regard to the LV were done in the parasternal long axis and in the apical 4-chamber view: interventricular septum, internal diameter of the cavity, left ventricular posterior wall, aortic diameter, left atrial diameter, left ventricular outflow tract, LV mass, end-systolic volume (ESV), end-diastolic volume (EDV), ejection fraction (EF), stroke volume, and cardiac output. ESV and EDV were calculated with the formula of Simpson.

2.3. Speckle-Tracking

Standard cross-sectional 2D images were recorded in the conventional B-mode and afterwards postprocessed on an external offline workstation. For parasternal short axis imaging the transducer was placed in the left parasternal region at the third and fourth intercostal space. The apical views were recorded with the transducer in the fifth intercostal space in the anterior axillary line close to or over the point of maximal impulse. Images were recorded at frame rates between 60 and 80 frames per second for optimal postprocessing measurements. Loops of at least three entire cardiac cycles of the LV were recorded in the cine loop format and synchronized to a 4-Lead ECG. Recordings were performed in a predetermined order using a preset with the following angles to assess the different dimensions of strain. Circumferential strain was measured in the parasternal short axis at the level of the papillary muscles. Longitudinal strain was assessed in the apical 4-, 3- and 2-chamber views. Longitudinal strain rate was detected in the apical 4-chamber view (apical, mid-, and basal septum).

2.4. Tissue-Doppler

Three consecutive heart beats were recorded as cine loops using color Doppler imaging at frame rates between 100 and 140 frames per second (fps) and >150 fps for the assessment of strain and strain rate, respectively. The ultrasound beam was aimed parallel to the movement of the myocardium to be analyzed in order to minimize angle deviation. Longitudinal strain was detected at a basal, mid-, and apical level of each wall. Circumferential strain was detected at the septum and free wall. Selection of echo windows and order of image acquisition were identical to those in the procedure for STE.

2.5. Stress Echocardiography

After the general echocardiographic studies, speckle-tracking and tissue-Doppler deformation analyses were utilized at three different levels of physical challenge: (1) in the resting state, (2) after cycling at a level of 50 Watts of resistance for two minutes, and (3) at 150 Watts resistance.

Strain and strain rate were assessed in the same procedure as described above with the participant being physically challenged riding a bicycle in a prone position. Cycling resistance was increased by 25 Watts every two minutes. The patients cycled in a prone position and the table was tilted 30 to 45 degrees to the left for image acquisition.

2.6. Postprocessing: Assessment of Strain

For speckle-tracking Q-analysis three recorded cardiac cycles were analyzed. The region of interest (ROI) was defined and single points were manually repositioned for optimal tissue-tracking. Strain and strain rate were calculated by the software and presented in a numeric and graphic manner.

For tissue-Doppler strain assessment, exact discrimination of the myocardium is an essential part of the procedure. Similar to the tracking procedure used in STE, the ROI for TDI analysis was defined by the examiner and timed at end-diastole and end-systole. Width and position of the area to be analyzed had to be adjusted manually. The same sample volume was used for all measurements. Angle deviation of the myocardial wall to the Doppler beam was kept to a minimum.

All echocardiographic analyses were performed by the same investigators, who were blinded to the patients’ clinical status at the time of assessment of strain and strain rate. The results were reproducible and intra- and interobserver variability were <3.2% in our study.

2.7. Statistical Methods

Hemodynamic data and clinical and echocardiographic characteristics of the two groups were described by mean and standard deviation. Box-Whisker Plots were used for the graphic representation of the data distribution. Fisher’s exact test was used to compare the two study groups with respect to gender. Hemodynamic data and clinical and echocardiographic characteristics of the two study groups were compared using the Mann-Whitney test. Wilcoxon matched-pairs signed-ranks test was used to compare STE and TDI data. Spearman’s rank correlation coefficient and multivariate analysis were utilized to rule out potential confounding of strain (rate) values by differing baseline characteristics. Values for were considered statistically significant. Stata IC/11.2 for Windows was used for all statistical analysis.

3. Results

3.1. Epidemiological Characteristics

Epidemiological characteristics including mean age and gender distribution did not differ between the groups except for body-weight-related parameters such as body mass index (28.5 in hypertensive patients versus 23.6 in control patients) (Table 2). Mean arterial blood pressure (BP) was significantly higher in the hypertensive group at rest (100.8 mmHg SD 13.5 mmHg; ), as well as during exercise testing at 50 Watts (110.7 mmHg SD 11.6 mmHg; ) and at 150 Watts resistance (124.2 mmHg SD 13.4 mmHg; ).

Table 2: Clinical characterisitcs of the entire study population and sub-group analysis, -values: Mann-Whitney--Test, Fischer’s exact test.

All subjects ()

Hypertensive ()
Control ()
-value

Sex
22 F, 24 M
25 F, 21 M
NS

Age (years)
46.6 SD 14.4
44 SD 22.5
NS

Height (cm)
174 SD 10.2
172.9 SD 9.2
NS

Weight (kg)
86 SD 21.4
70.8 SD 11.9
0.000

BMI
28.5 SD 7.6
23.6 SD 3
0.000

BSA (m²)
2 SD 0.2
1.8 SD 0.2
0.001

At rest
Systolic BP (mmHg)
131 SD 20.5
121.7 SD 16.7
0.043

Diastolic BP (mmHg)
85.7 SD 13.5
78.8 SD 10.8
0.011

Mean BP (mmHg)
100.8 SD 13.5
93.1 SD 10.5
0.002

Heart rate (bpm)
69.3 SD 11.8
72.4 SD 15.1
NS

EF (%)
56.3 SD 7.6
57.2 SD 7.2
NS

50 W
Systolic BP (mmHg)
152.0 SD 19.9
147.9 SD 19
NS

Diastolic BP (mmHg)
90.1 SD 12.2
80.5 SD 11.3
0.000

Mean BP (mmHg)
110.7 SD 11.6
103 SD 10.2
0.000

Heart rate (bpm)
107.4 SD 13.2
113.2 SD 16
NS

EF (%)
58.2 SD 8.1
59.5 SD 8.1
NS

150 W
Systolic BP (mmHg)
185.3 SD 23.4
175.8 SD 22.2
0.016

Diastolic BP (mmHg)
93.6 SD 11.6
86.4 SD 12.9
0.008

Mean BP (mmHg)
124.2 SD 13.4
116.2 SD 14.1
0.003

Heart rate (bpm)
124.5 SD 15.8
140.2 SD 18.1
0.000

EF (%)
59.8 SD 8.1
61.9 SD 6.6
NS

Ejection fraction, fractional shortening of the midwall, and E/A-wave ratio were not significantly different between the groups (Table 3). Even though conventional echocardiographic parameters showed minor differences between the groups, parameters were within normal limits according to ASE/AHA recommendations [22, 23]. Conventional exercise echocardiography showed no wall motion abnormalities and exercise EKG was normal in all subjects of both groups. Spearman’s rank correlation and multivariate analyses were conducted to rule out LV mass, body weight, BMI, and body surface area as potential confounding factors.

Table 3: General echocardiographic characteristics of the study population, -values were calculated with the Mann-Whitney- test.

All subjects ()

Hypertensive ()
Control ()
-value

Left atrial diameter (cm)
3.1 SD 0.5
2.9 SD 0.5
0.022

Interventricular septal diameter, diastolic (cm)
1 SD 0.2
0.9 SD 0.2
0.016

Interventricular septal diameter, systolic (cm)
1.5 SD 0.2
1.3 SD 0.2
0.020

LV cavity diameter, diastolic (cm)
5.4 SD 0.5
4.3 SD 0.5
0.011

LV cavity diameter, systolic (cm)
3.1 SD 0.5
3 SD 0.5
NS

LV posterior wall diameter, diastolic (cm)
1.1 SD 0.2
1 SD 0.2
NS

LV posterior wall diameter, systolic (cm)
1.5 SD 0.4
1.4 SD 0.2
NS

Fractional shortening of the mid-wall (%)
32 SD 6.6
31.3 SD 5.6
NS

Stroke volume (mL)
57.2 SD 14.5
48.3 SD 15
0.001

Left ventricular mass (g)
188.4 SD 59.4
148.8 SD 44.2
0.001

LV mass/body surface area (g/m²)
96.8 SD 30.6
81.1 SD 21.3
0.020

E-Wave/A-Wave
1.2 SD 0.4
1.4 SD 0.5
NS

E-Wave/EI-Wave
9.3 SD 2.4
7.4 SD 1.7
0.000

Iso-volumetric contraction time (ms)
79.6 SD 17
72 SD 13.3
0.038

Iso-volumetric relaxation time (ms)
85.5 SD 16.7
84.5 SD 13.7
NS

3.2. Peak LV Strain Values Are Reduced in Patients with Arterial Hypertension

Participants with arterial hypertension had lower peak strain values than healthy controls using both speckle-tracking (STE) and tissue-Doppler imaging (TDI) (Figure 1(a)). Specifically, hypertensive subjects showed significantly lower peak LV strain values for circumferential strain (CS) () as well as longitudinal strain (LS) () in the 2-, 3-, and 4-chamber view both at rest () and during exercise testing () (Table 4) (Figures 1(b) and 1(c)). STE- and TDI-derived strain levels showed similar results (Figure 1). At rest healthy participants showed significantly higher strain values in CS () and LS (). After cycling at a resistance of 50 Watts for two minutes healthy controls had significantly higher values in CS () and LS in the 2-chamber (), in the 3-chamber (), and in the 4-chamber view () compared to hypertensive patients. Similar results were found at maximal resistance during exercise echocardiography (Table 5). Subgroup analyses revealed no differences in strain and strain rate between hypertensive patients with and without beta-adrenergic blocking agents (data not shown).

Table 4: Tissue-doppler: peak LV strain at rest and during stress echocardiography.

All subjects ()

Hypertensive ()
Control ()
-value

At rest

Circumferential
−18.9 SD 2.6
−22.2 SD 2.1
<0.001

Longitudinal (2)
−18.3 SD 2.1
−20.8 SD 2.3
<0.001

Longitudinal (3)
−17.3 SD 4.1
−19.2 SD 2.4
<0.001

Longitudinal (4)
−18.0 SD 2.3
−20.1 SD 2.3
<0.001

50 Watts

Circumferential
−19.5 SD 3.1
−23.1 SD 4.4
<0.001

Longitudinal (2)
−19.1 SD 2.7
−21.6 SD 2.2
<0.001

Longitudinal (3)
−17.9 SD 2.3
−21.1 SD 2.5
<0.001

Longitudinal (4)
−18.9 SD 2.2
−21.5 SD 3.0
<0.001

150 Watts

Circumferential
−19.8 SD 3.8
−23.9 SD 3.6
<0.001

Longitudinal (2)
−19.4 SD 2.6
−22.1 SD 2.5
<0.001

Longitudinal (3)
−18.6 SD 2.0
−21.8 SD 3.0
<0.001

Longitudinal (4)
−19.3 SD 2.6
−22.5 SD 2.9
<0.001

Table 5: Speckle-tracking: peak LV strain at rest and during stress echocardiography.

All subjects ()

Hypertensive ()
Control ()
-value

At rest

Circumferential
−17.2 SD 3.0
−19.9 SD 3.7
0.001

Longitudinal (2)
−17.6 SD 3.4
−20.1 SD 3.7
0.002

Longitudinal (3)
−17.9 SD 3.4
−19.8 SD 3.2
0.010

Longitudinal (4)
−18.2 SD 3.3
−19.6 SD 3.0
0.014

50 Watts

Circumferential
−17.6 SD 4.2
−21.2 SD 3.4
<0.001

Longitudinal (2)
−19.3 SD 3.6
−21.4 SD 3.8
0.010

Longitudinal (3)
−19.5 SD 3.5
−20.9 SD 2.5
0.033

Longitudinal (4)
−19.5 SD 2.9
−21.0 SD 3.1
0.011

150 Watts

Circumferential
−18.2 SD 4.3
−22.2 SD 3.6
<0.001

Longitudinal (2)
−18.6 SD 4.2
−21.6 SD 4.1
0.005

Longitudinal (3)
−18.9 SD 3.4
−21.0 SD 3.6
0.011

Longitudinal (4)
−19.7 SD 3.3
−20.7 SD 3.4
NS

(a)

(b)

(c)

Figure 1: Tissue-Doppler-derived and speckle-tracking-derived circumferential and longitudinal global strain of hypertensive patients and healthy controls (a) at rest, (b) at 50 Watts resistance, and (c) at 150 Watts resistance during physical stress echocardiography. TDI: tissue-Doppler imaging; STE: speckle-tracking echocardiography; ; ; values were calculated with the Mann-Whitney- test and Wilcoxon signed-rank test.

3.3. The Increase of LV Peak Strain during Stress Is Impaired in Patients with Arterial Hypertension

The degree of the increase in LV systolic strain was measured using STE and TDI. Hypertensive patients had a weaker increase in peak strain during physical exercise which was detected slightly more distinctively with TDI than with STE. TDI could detect significant increases in CS () and LS () in nine out of sixteen comparisons, mostly in the healthy control group (Supplementary Table 1; Supplementary Material available online at http://dx.doi.org/10.1155/2014/472562). Nonsignificant results showed the same tendency with a stronger increase in strain for the control group. STE analyses showed similar findings (Supplementary Table 2).

3.4. Hypertensive Patients Have Reduced Peak Systolic Strain Rate at Rest and during Exercise

LV myocardial contractility was measured using STE and TDI. Strain rate was reduced both at rest () as well as during exercise testing () in patients with arterial HTN. This was shown both with STE and TDI. The degree of the increase in LV systolic contractility was higher in the control group (Figures 2 and 3).

Figure 2: Longitudinal strain rate at rest and during physical stress echocardiography in hypertensive patients and healthy controls assessed with tissue-Doppler and speckle-tracking. TDI: tissue-Doppler imaging; STE: speckle-tracking echocardiography; ; ; values were calculated with the Mann-Whitney test and Wilcoxon signed-rank test.

(a)

(b)

Figure 3: Speckle-tracking. Longitudinal strain rate at maximal stress during exercise echocardiography (a) in a hypertensive patient and (b) in a healthy control. Note the difference in maximal strain rate during early systole.

4. Discussion

4.1. LV Myocardial Deformation in Arterial Hypertension

This study demonstrates reduced levels of peak LV systolic peak strain and strain rate at rest in patients with mild arterial hypertension, while conventional echocardiographic parameters such as ejection fraction (EF) and fractional shortening of the midwall (FS) remained unchanged when compared to healthy control patients. Similar findings have recently been shown in an experimental setting for myocardial hypertrophy in rats [24]. In our study, these differences became more pronounced during physical exercise using both speckle-tracking (STE) and tissue-Doppler imaging (TDI). This is in line with the findings of Atilgan et al. who found patients with mild arterial hypertension to have reduced LV longitudinal deformation [25].

Since there were no significant differences in EF and FS between the groups at the moment of investigation, the observed changes most likely reflect cardiac changes due to longstanding arterial hypertension, evident before conventional echocardiographic parameters values become pathologic. It currently remains unclear whether or not these changes can be reversible by adequate blood pressure control, but considering the extent of the observed changes in our study we consider it rather unlikely. Nevertheless, in order to answer this question longitudinal analyses on a large patient cohort with isolated arterial hypertension are necessary.

Furthermore, due to the fact that functional alterations occur inhomogenously in myocardial hypertrophy [26, 27], varying observations for regional versus global systolic strain can be explained. The question of which is the most appropriate aspect of the myocardium for the assessment of strain in this diagnostic content has yet to be addressed.

4.2. Quantitative Deformation Analysis during Physical Exercise

Even though stress echocardiography is a powerful diagnostic instrument in the hands of experienced echocardiographers, the value of stress echocardiography as a tool for clinical decision making in myocardial disease is still limited by subjective endocardial border definition and differences in interindividual interpretation of regional wall motion abnormalities. These limitations eventually led to the development of more quantitative methods [28–31] some of which bear true advantages especially for less experienced examiners [32, 33] as, for example, tissue-Doppler imaging which has been showed to be as accurate as visual interpretation by experts [33]. In our study we investigated the value of two quantitative methods, namely, tissue-Doppler (TDI) and speckle-tracking (STE), in assessing mild cardiac abnormalities in hypertensive patients. We could show that hypertensive patients have a less pronounced increase in LV deformation during physical exercise compared to healthy individuals (Figure 1). Both STE and TDI were able to accurately detect peak systolic LV strain values during exercise echocardiography (Tables 4 and 5). Furthermore, the absolute increase in myocardial strain during stress echocardiography (Supplementary Tables 1 and 2) as well as differences in strain rate during exercise testing (Table 6) were significantly different between the two groups as measured by STE and TDI. This first enables STE and TDI to differentiate healthy controls from patients in which strain and strain rate do not increase as much as a result of systolic impairment due to longstanding arterial hypertension. While differences in myocardial contractility were already present at rest in the population we examined in this study, the incremental value of stress testing becomes evident when looking at the development of strain rate during exercise testing. This shows a much more pronounced difference between peak systolic strain rates in hypertensive versus healthy patients at maximal resistance when compared to the resting state (Figure 2). A more subtle change in myocardial strain (rate) might not necessarily become evident at rest and therefore require the addition of STE or TDI during stress testing.

Table 6: Speckle-tracking and tissue-Doppler: Strain rate at rest and during stress testing; -values are calculated with the Mann-Whitney--test.

Hypertensive ()
Control ()
-value

At rest

STE (entire septum)
−1.25 SD 0.57
−1.28 SD 0.21
0.037

STE (basal septum)
−1.22 SD 0.42
−1.17 SD 0.31
NS

TDI (entire septum)
−1.16 SD 0.19
−1.37 SD 0.27
<0.001

TDI (basal septum)
−1.24 SD 0.27
−1.39 SD 0.37
0.030

50 Watts

STE (entire septum)
−1.65 SD 0.36
−1.86 SD 0.33
0.002

STE (basal septum)
−1.56 SD 0.56
−1.72 SD 0.49
NS

TDI (entire septum)
−1.55 SD 0.25
−2.00 SD 0.39
<0.001

TDI (basal septum)
−1.63 SD 0.30
−2.06 SD 0.42
<0.001

150 Watts

STE (entire septum)
−1.87 SD 0.37
−2.35 SD 0.53
<0.001

STE (basal septum)
−1.93 SD 0.63
−2.30 SD 0.64
0.004

TDI (entire septum)
−1.85 SD 0.30
−2.42 SD 0.49
<0.001

TDI (basal septum)
−1.85 SD 0.41
−2.55 SD 0.65
<0.001

In consequence, both TDI- and STE-derived LV peak strain and strain rate during bicycle stress echocardiography are a useful tool to detect early impairment of myocardial function due to longstanding arterial hypertension. This is supported by data presented by Hanekom et al. who proved that quantitative echocardiography in combination with exercise testing is feasible in an angiographic correlation study [34].

4.3. Regional Strain Rate May Underestimate Contractility in the Resting State

Strain rate was measured at rest and during exercise in both groups using STE and TDI at the basal septum only as well as at the entire septum. TDI-derived strain rate values showed a more marked difference between the two groups when compared to STE which becomes less evident at increasing resistance during exercise (Figure 2, Table 6). Interestingly, strain rate values derived locally from the basal septum were less able to distinguish between the hypertensive and healthy hearts when compared to analyzing the entire septum. This effect is stronger for STE and becomes less emphasized at increasing stress levels. Due to these findings, it is therefore important to compare various segments when analyzing strain rate in the resting state, whereas the assessment of a single segment seems to be sufficient during exercise testing. This goes partly in line with the findings of Ingul et al. who showed that mean global (versus regional) strain rate is a good predictor for clinical outcome in patients with abnormal wall motion during stress echocardiography [35].

4.4. Study Limitations

In general, despite the promise that quantitative deformation imaging offers, there are still a number of challenges limiting its clinical utility such as time consuming image acquisition, complex methodology, technological requirements, and a lack of consensus regarding optimal parameters and methods [36, 37].

TDI, for example, bears considerable limitations such as angle dependency, the requirement of high frame rates, and the fact that it is prone to artifacts [38, 39]. Misalignment of the insonation angle with the true wall orientation can significantly underestimate strain. While two-dimensional speckle-tracking works on a different technical principle and is therefore an angle-independent method [16, 40], it also has its limitations. For instance, recognized speckles are only detected in a two-dimensional plane, whereas cardiac fibers contract in a three-dimensional manner. Thus, speckles move out of the detectable area. Even though, the software compensates for this by detection of new speckles as they move into the scanned plane [40], low-frame rates still lead to undersampling and speckles move out of the scanned area too soon for digital compensation. High frame rates can reduce this problem but lead to inadequate tracking due to decreased spatial resolution.

5. Conclusions

Hypertensive heart disease with normal ejection fraction is associated with reduced peak LV systolic contractility. Speckle-tracking and tissue-Doppler showed depressed LV strain and strain rate in patients with arterial hypertension both at rest and more pronounced during physical stress echocardiography. These findings target strain and strain rate as early parameters for preventive strategies in hypertensive heart disease. Further studies and widespread application of these novel techniques are needed in order to facilitate a more focused utilization and hereby improve their clinical applicability.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Kai O. Hensel has performed all the echocardiographic studies, postprocessing analyses, and wrote the paper. Andreas Jenke helped in writing the paper and gave support regarding figures and data presentation. Roman Leischik has designed and supervised the study, supported and planed biostatistical input and figures, helped in writing the paper, had helped recruiting patients, and was involved in the interobserver variability measurements.

Acknowledgments

Special thanks go to Dr. Claudia Schönenstein, Dr. Kurt-Martin Schmelzer, and Martina Freund for their help regarding the acquisition of patients and volunteers, to Birgit Dworrak for her great organizational help, to Hiltrud Niggemann for her biostatistical input, to Martin Lesniak for his help regarding the layout, to Marc Vorpahl for his helpful review of the paper, and to Alexandra Fleissner for technical support.

References

D. Lloyd-Jones, R. J. Adams, T. M. Brown et al., “Heart disease and stroke statistics-2010 update: a report from the american heart association,” Circulation, vol. 121, no. 7, pp. e46–e215, 2010.

F. Lopez-Jimenez, J. A. Batsis, V. L. Roger, L. Brekke, H. H. Ting, and V. K. Somers, “Trends in 10-Year predicted risk of cardiovascular disease in the United States, 1976 to 2004,” Circulation: Cardiovascular Quality and Outcomes, vol. 2, no. 5, pp. 443–450, 2009.

E. D. Frohlich, C. Apstein, A. V. Chobanian et al., “The heart in hypertension,” New England Journal of Medicine, vol. 327, no. 14, pp. 998–1008, 1992.

B. H. Lorell and B. A. Carabello, “Left ventricular hypertrophy: pathogenesis, detection, and prognosis,” Circulation, vol. 102, no. 4, pp. 470–479, 2000.

J. P. Curtis, S. I. Sokol, Y. Wang et al., “The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure,” Journal of the American College of Cardiology, vol. 42, no. 4, pp. 736–742, 2003.

P. R. Liebson, G. Grandits, R. Prineas et al., “Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS),” Circulation, vol. 87, no. 2, pp. 476–486, 1993.

O. H. Bing, S. Matsushita, B. L. Fanburg, and H. J. Levine, “Mechanical properties of rat cardiac muscle during experimental hypertrophy,” Circulation Research, vol. 28, no. 2, pp. 234–245, 1971.

R. Jacob, M. Vogt, and H. Rupp, “Pathophysiological mechanisms in cardiac insufficiency induced by chronic pressure overload—an attempt to analyzed specific factors in animal experiment,” Basic Research in Cardiology, vol. 81, no. 1, pp. 203–216, 1986.

J. F. Spann Jr., R. A. Buccino, E. H. Sonnenblick, and E. Braunwald, “Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure.,” Circulation Research, vol. 21, no. 3, pp. 341–354, 1967.

G. C. Nesbitt, S. Mankad, and J. K. Oh, “Strain imaging in echocardiography: methods and clinical applications,” The International Journal of Cardiovascular Imaging, vol. 25, supplement 1, pp. 9–22, 2009.

L. C. Afonso, J. Bernal, J. J. Bax, and T. P. Abraham, “Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies,” JACC: Cardiovascular Imaging, vol. 1, no. 6, pp. 787–800, 2008.

A. D'Andrea, P. Caso, E. Bossone et al., “Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle-tracking two-dimensional strain analysis,” European Journal of Echocardiography, vol. 11, no. 6, pp. 492–500, 2010.

N. J. Artis, D. L. Oxborough, G. Williams, C. B. Pepper, and L. B. Tan, “Two-dimensional strain imaging: a new echocardiographic advance with research and clinical applications,” International Journal of Cardiology, vol. 123, no. 3, pp. 240–248, 2008.

T. Edvardsen, B. L. Gerber, J. Garot, D. A. Bluemke, J. A. C. Lima, and O. A. Smiseth, “Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging,” Circulation, vol. 106, no. 1, pp. 50–56, 2002.

V. Di Bello, M. Galderisi, C. De Gregorio et al., “New echocardiographic technologies in the clinical management of hypertensive heart disease,” Journal of Cardiovascular Medicine, vol. 8, no. 12, pp. 997–1006, 2007.

M. Leitman, P. Lysyansky, S. Sidenko et al., “Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function,” Journal of the American Society of Echocardiography, vol. 17, no. 10, pp. 1021–1029, 2004.

E. Imbalzano, C. Zito, S. Carerj et al., “Left ventricular function in hypertension: new insight by speckle tracking echocardiography,” Echocardiography, vol. 28, no. 6, pp. 649–657, 2011.

G. John III, A. Deswal, S. Mankad et al., “Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient,” The American Journal of Cardiology, vol. 81, no. 5, pp. 615–623, 1998.

D. Vinereanu, N. Florescu, N. Sculthorpe, A. C. Tweddel, M. R. Stephens, and A. G. Fraser, “Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes,” The American Journal of Cardiology, vol. 88, no. 1, pp. 53–58, 2001.

N. Cardim, S. Longo, T. Ferreira et al., “Tissue Doppler imaging assessment of long axis left ventricular function in hypertensive patients with concentric left ventricular hypertrophy: differential diagnosis with hypertrophic cardiomyopathy.,” Revista Portuguesa de Cardiologia, vol. 21, no. 6, pp. 709–740, 2002.

A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report,” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003.

R. M. Lang, M. Bierig, R. B. Devereux et al., “Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology,” Journal of the American Society of Echocardiography, vol. 18, no. 12, pp. 1440–1463, 2005.

S. F. Nagueh, C. P. Appleton, T. C. Gillebert et al., “Recommendations for the evaluation of left ventricular diastolic function by echocardiography,” Journal of the American Society of Echocardiography, vol. 22, no. 2, pp. 107–133, 2009.

R. Koshizuka, T. Ishizu, Y. Kameda, R. Kawamura, Y. Seo, and K. Aonuma, “Longitudinal strain impairment as a marker of the progression of heart failure with preserved ejection fraction in a rat model,” Journal of the American Society of Echocardiography, vol. 26, no. 3, pp. 316–323, 2013.

D. Atilgan, A. K. Bilge, I. Onur, B. Pamukçu, M. Özcan, and K. Adalet, “Assessment of longitudinal left ventricular systolic function by different echocardiographic modalities in patients with newly diagnosed mild-to-moderate hypertension,” Anadolu Kardiyoloji Dergisi, vol. 10, no. 3, pp. 247–252, 2010.

R. W. W. Biederman, M. Doyle, A. A. Young et al., “Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: alosartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy,” Hypertension, vol. 52, no. 2, pp. 279–286, 2008.

J. Ganame, L. Mertens, B. W. Eidem et al., “Regional myocardial deformation in children with hypertrophic cardiomyopathy: Morphological and clinical correlations,” European Heart Journal, vol. 28, no. 23, pp. 2886–2894, 2007.

J. Voigt, B. Exner, K. Schmiedehausen et al., “Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia,” Circulation, vol. 107, no. 16, pp. 2120–2126, 2003.

T. H. Marwick, “Quantitative techniques for stress echocardiography: dream or reality?” European Journal of Echocardiography, vol. 3, no. 3, pp. 171–176, 2002.

L. Hatle and G. R. Sutherland, “Regional myocardial function—a new approach,” European Heart Journal, vol. 21, no. 16, pp. 1337–1357, 2000.

O. Najos-Valencia, P. Cain, C. Case, S. Wahi, and T. H. Marwick, “Determinants of tissue Doppler measures of regional diastolic function during dobutamine stress echocardiography,” American Heart Journal, vol. 144, no. 3, pp. 516–523, 2002.

R. Koch, R. M. Lang, M. Garcia et al., “Objective evaluation of regional left ventricular wall motion during dobutamine stress echocardiographic studies using segmental analysis of color kinesis images,” Journal of the American College of Cardiology, vol. 34, no. 2, pp. 409–419, 1999.

R. Fathi, P. Cain, S. Nakatani, H. C. M. Yu, and T. H. Marwick, “Effect of tissue Doppler on the accuracy of novice and expert interpreters of dobutamine echocardiography,” The American Journal of Cardiology, vol. 88, no. 4, pp. 400–405, 2001.

L. Hanekom, G.-Y. Cho, R. Leano, L. Jeffriess, and T. H. Marwick, “Comparison of two-dimensional speckle and tissue Doppler strain measurement during dobutamine stress echocardiography: an angiographic correlation,” European Heart Journal, vol. 28, no. 14, pp. 1765–1772, 2007.

C. B. Ingul, E. Rozis, S. A. Slordahl, and T. H. Marwick, “Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography,” Circulation, vol. 115, no. 10, pp. 1252–1259, 2007.

T. H. Marwick, “Measurement of strain and strain rate by echocardiography: ready for prime time?” Journal of the American College of Cardiology, vol. 47, no. 7, pp. 1313–1327, 2006.

R. Citro, E. Bossone, B. Kuersten, G. Gregorio, and A. Salustri, “Tissue Doppler and strain imaging: anything left in the echo-lab?” Cardiovascular Ultrasound, vol. 6, article 54, 2008.

P. L. Castro, N. L. Greenberg, J. Drinko, M. J. Garcia, and J. D. Thomas, “Potential pitfalls of strain rate imaging: angle dependency,” Biomedical Sciences Instrumentation, vol. 36, pp. 197–202, 2000.

N. P. Nikitin and K. K. A. Witte, “Application of Tissue Doppler Imaging in Cardiology,” Cardiology, vol. 101, no. 4, pp. 170–184, 2004.

T. Toyoda, H. Baba, T. Akasaka et al., “Assessment of regional myocardial strain by a novel automated tracking system from digital image files,” Journal of the American Society of Echocardiography, vol. 17, no. 12, pp. 1234–1238, 2004.